a cure for hep c, aids, the flu and dengue..., page-81

I'd just like to quickly note that these shares are still trading with a hefty PR-discount (or, more appropriately, a no-PR-discount). From the front page of the Biotron website:

"Biotron Limited is an Australian biotechnology company developing and commercializing novel therapeutics and diagnostics to address a range of significant health issues.

Biotron's current focus is on development of novel antiviral therapeutics and high-throughput screening technologies for cancer diagnosis. In addition, the Company has a number of early-stage projects targeting other indications such as cardiovascular disease."

Cancer diagnosis?! Cardiovascular disease!?! Not a mention of BIT225. Even the antiviral mention is just a reference to the old Virion program.

Get your discount here folks....